Phenotype and Functionality of CD4+ and CD8+ T Cells in the Upper Reproductive Tract of Healthy Premenopausal Women

American Journal of Reproductive Immunology

Volumn 71, Issue 2, 2014, Pages 95-108

  Shanmugasundaram, Uma ^a   Critchfield, J William ^a   Pannell, Jane ^b   Perry, Jean ^c   Giudice, Linda C ^c   Smith Mccune, Karen ^c   Greenblatt, Ruth M ^b,c   Shacklett, Barbara L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CTL; Endocervix; Endometrium; HIV; STD; T cell

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; CCR5 PROTEIN, HUMAN; CYTOKINE;

ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CURETTAGE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EFFECTOR CELL; ENDOCERVICAL CURETTAGE; ENDOMETRIAL BRUSH; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; LUTEAL PHASE; LYMPHOCYTE ACTIVATION; MEMORY CELL; NORMAL HUMAN; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESEARCH; T LYMPHOCYTE ACTIVATION; UTERINE ENDOCERVIX; ADULT; CELL CULTURE; CELL SEPARATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; T LYMPHOCYTE SUBPOPULATION; UTERINE CERVIX; WOMEN'S HEALTH;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CELLS, CULTURED; CERVIX UTERI; CYTOKINES; ENDOMETRIUM; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; PREMENOPAUSE; RECEPTORS, CCR5; T-LYMPHOCYTE SUBSETS; WOMEN'S HEALTH;

EID: 84892438811     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12182     Document Type: Article

References (72)

1. Miller L, Patton DL, Meier A, Thwin SS, Hooton TM, Eschenbach DA: Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 2000; 96:431-439.
2. Norvell MK, Benrubi GI, Thompson RJ: Investigation of microtrauma after sexual intercourse. J Reprod Med 1984; 29:269-271.
3. Kaushic C: HIV-1 infection in the female reproductive tract: role of interactions between HIV-1 and genital epithelial cells. Am J Reprod Immunol 2011; 65:253-260.
4. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L: Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005; 206:306-335.
5. Wira CR, Fahey JV: A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008; 22:1909-1917.
6. Nasu K, Narahara H: Pattern recognition via the toll-like receptor system in the human female genital tract. Mediators Inflamm 2010; 2010:976024.
7. Ghosh M, Shen Z, Fahey JV, Crist SG, Patel M, Smith JM, Wira CR: Pathogen recognition in the human female reproductive tract: expression of intracellular cytosolic sensors NOD1, NOD2, RIG-1, and MDA5 and response to HIV-1 and Neisseria gonorrhea. Am J Reprod Immunol 2013; 69:41-51.
8. Hunt JS: Immunologically relevant cells in the uterus. Biol Reprod 1994; 50:461-466.
9. Wira CR, Fahey JV, Ghosh M, Patel MV, Hickey DK, Ochiel DO: Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. Am J Reprod Immunol 2010; 63:544-565.
10. Givan AL, White HD, Stern JE, Colby E, Gosselin EJ, Guyre PM, Wira CR: Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 1997; 38:350-359.
11. Wira CR, Patel MV, Ghosh M, Mukura L, Fahey JV: Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol 2011; 65:196-211.
12. Valore EV, Park CH, Igreti SL, Ganz T: Antimicrobial components of vaginal fluid. Am J Obstet Gynecol 2002; 187:561-568.
13. Keller MJ, Guzman E, Hazrati E, Kasowitz A, Cheshenko N, Wallenstein S, Cole AL, Cole AM, Profy AT, Wira CR, Hogarty K, Herold BC: PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity. AIDS 2007; 21:467-476.
14. Horne AW, Stock SJ, King AE: Innate immunity and disorders of the female reproductive tract. Reproduction 2008; 135:739-749.
15. + CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol 1997; 158:3017-3027.
16. White HD, Yeaman GR, Givan AL, Wira CR: Mucosal immunity in the human female reproductive tract: cytotoxic T lymphocyte function in the cervix and vagina of premenopausal and postmenopausal women. Am J Reprod Immunol 1997; 37:30-38.
17. Ma Z, Lu FX, Torten M, Miller CJ: The number and distribution of immune cells in the cervicovaginal mucosa remain constant throughout the menstrual cycle of rhesus macaques. Clin Immunol 2001; 100:240-249.
18. Hladik F, Hope TJ: HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep 2009; 6:20-28.
19. Haase AT: Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010; 464:217-223.
20. Li Q, Skinner PJ, Ha SJ, Duan L, Mattila TL, Hage A, White C, Barber DL, O'Mara L, Southern PJ, Reilly CS, Carlis JV, Miller CJ, Ahmed R, Haase AT: Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 2009; 323:1726-1729.
21. Keele BF, Estes JD: Barriers to mucosal transmission of immunodeficiency viruses. Blood 2011; 118:839-846.
22. Coombs RW, Reichelderfer PS, Landay AL: Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 2003; 17:455-480.
23. De Jonge C: Biological basis for human capacitation. Hum Reprod Update 2005; 11:205-214.
24. Beagley KW, Gockel CM: Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003; 38:13-22.
25. Shacklett BL, Yang O, Hausner MA, Elliott J, Hultin L, Price C, Fuerst M, Matud J, Hultin P, Cox C, Ibarrondo J, Wong JT, Nixon DF, Anton PA, Jamieson BD: Optimization of methods to assess human mucosal T-cell responses to HIV infection. J Immunol Methods 2003; 279:17-31.
26. + T cells to gut-associated lymphoid tissue during chronic infection. J Virol 2003; 77:5621-5631.
27. Roederer M: Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 2001; 45:194-205.
28. + T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection. J Virol 2007; 81:5460-5471.
29. + T-cell responses during chronic infection reflect clinical status. PLoS ONE 2008; 3:e3577.
30. Holm S: A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6:65-70.
31. Shacklett BL, Greenblatt RM: Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications. Am J Reprod Immunol 2011; 65:230-241.
32. Groot F, van Capel TM, Schuitemaker J, Berkhout B, de Jong EC: Differential susceptibility of naive, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission. Retrovirology 2006; 3:52.
33. + T cells. Nature 2005; 434:1148-1152.
34. Sallusto F, Geginat J, Lanzavecchia A: Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:745-763.
35. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-712.
36. Michie CA, McLean A, Alcock C, Beverley PC: Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 1992; 360:264-265.
37. Gumbi PP, Jaumdally SZ, Salkinder AL, Burgers WA, Mkhize NN, Hanekom W, Coetzee D, Williamson A, Passmore JS: CD4 T cell depletion at the cervix during HIV infection is associated with accumulation of terminally differentiated T cells. J Virol 2011; 85:13333-13341.
38. Levacher M, Hulstaert F, Tallet S, Ullery S, Pocidalo JJ, Bach BA: The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol 1992; 90:376-382.
39. + memory cytotoxic T-lymphocytes (CTL) against HIV-1 with respect to expression of CD45RA/RO, CD62L and CD28 antigens. Immunol Lett 1999; 66:105-110.
40. Begaud E, Chartier L, Marechal V, Ipero J, Leal J, Versmisse P, Breton G, Fontanet A, Capoulade-Metay C, Fleury H, Barre-Sinoussi F, Scott-Algara D, Pancino G: Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 2006; 3:35.
41. + T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo. J Virol 2011; 85:10189-10200.
42. Pancino G, Saez-Cirion A, Scott-Algara D, Paul P: Natural resistance to HIV infection: lessons learned from HIV-exposed uninfected individuals. J Infect Dis 2010; 202(Suppl 3):S345-S350.
43. Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ: Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 2006; 12:289-295.
44. Gumbi PP, Nkwanyana NN, Bere A, Burgers WA, Gray CM, Williamson AL, Hoffman M, Coetzee D, Denny L, Passmore JA: Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection. J Virol 2008; 82:8529-8536.
45. Levinson P, Kaul R, Kimani J, Ngugi E, Moses S, MacDonald KS, Broliden K, Hirbod T: Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS 2009; 23:309-317.
46. Chege D, Chai Y, Huibner S, Kain T, Wachihi C, Kimani M, Barasa S, McKinnon LR, Muriuki FK, Kariri A, Jaoko W, Anzala O, Kimani J, Ball TB, Plummer FA, Kaul R: Blunted IL17/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in Kenya. PLoS ONE 2012; 7:e43670.
47. Patterson BK, Landay A, Andersson J, Brown C, Behbahani H, Jiyamapa D, Burki Z, Stanislawski D, Czerniewski MA, Garcia P: Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol 1998; 153:481-490.
48. Sheffield JS, Wendel GD Jr, McIntire DD, Norgard MV: The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression. Reprod Sci 2009; 16:20-31.
49. + T cells in healthy postmenopausal women. J Acquir Immune Defic Syndr 2012; 59:221-228.
50. Vishwanathan SA, Guenthner PC, Lin CY, Dobard C, Sharma S, Adams DR, Otten RA, Heneine W, Hendry RM, McNicholl JM, Kersh EN: High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J Acquir Immune Defic Syndr 2011; 57:261-264.
51. Saba E, Origoni M, Taccagni G, Ferrari D, Doglioni C, Nava A, Lisco A, Grivel JC, Margolis L, Poli G: Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle. Mucosal Immunol 2013; 6:1081-1090.
52. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten JM: Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012; 12:19-26.
53. Centers for Disease Control and Prevention: U S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Recomm Rep 2010;59:1-86.
54. Centers for Disease Control and Prevention: Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV. MMWR Morb Mortal Wkly Rep 2012;61:449-452.
55. + T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol 2011; 187:6032-6042.
56. Prakash M, Kapembwa MS, Gotch F, Patterson S: Higher levels of activation markers and chemokine receptors on T lymphocytes in the cervix than peripheral blood of normal healthy women. J Reprod Immunol 2001; 52:101-111.
57. Lawrence P, Portran D, Terrasse R, Palle S, Olivier T, Fantini J, Bourlet T, Pozzetto B, Delezay O: Selective transmigration of monocyte-associated HIV-1 across a human cervical monolayer and its modulation by seminal plasma. AIDS 2012; 26:785-796.
58. Yeaman GR, Howell AL, Weldon S, Demian DJ, Collins JE, O'Connell DM, Asin SN, Wira CR, Fanger MW: Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection. Immunology 2003; 109:137-146.
59. + T cells into the interstitium of the normal lung. J Clin Invest 2005; 115:3473-3483.
60. Nkwanyana NN, Gumbi PP, Roberts L, Denny L, Hanekom W, Soares A, Allan B, Williamson AL, Coetzee D, Olivier AJ, Burgers WA, Passmore JA: Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract. Immunology 2009; 128:e746-e757.
61. Yeaman GR, White HD, Howell A, Prabhala R, Wira CR: The mucosal immune system in the human female reproductive tract: potential insights into the heterosexual transmission of HIV. AIDS Res Hum Retroviruses 1998; 14(Suppl 1):S57-S62.
62. Mselle TF, Meadows SK, Eriksson M, Smith JM, Shen L, Wira CR, Sentman CL: Unique characteristics of NK cells throughout the human female reproductive tract. Clin Immunol 2007; 124:69-76.
63. Eslahpazir J, Jenabian MA, Bouhlal H, Hocini H, Carbonneil C, Gresenguet G, Mbopi Keou FX, LeGoff J, Saidi H, Requena M, Nasreddine N, de Dieu Longo J, Kaveri SV, Belec L: Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions. Clin Vaccine Immunol 2008;15:872-884.
64. Saidi H, Magri G, Carbonneil C, Nasreddine N, Requena M, Belec L: IFN-gamma-activated monocytes weakly produce HIV-1 but induce the recruitment of HIV-sensitive T cells and enhance the viral production by these recruited T cells. J Leukoc Biol 2007; 81:642-653.
65. + Th1 phenotype. J Immunol 1999; 163:2306-2313.
66. Passmore JA, Milner M, Denny L, Sampson C, Marais DJ, Allan B, Gumbi PP, Hitzeroth II, Rybicki EP, Williamson AL: Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia. Immunology 2006; 119:507-514.
67. Shacklett BL: Cell-mediated immunity to HIV in the female reproductive tract. J Reprod Immunol 2009; 83:190-195.
68. + T cells, and AIDS. J Virol 1997; 71:4016-4023.
69. Barnhart KT, Stolpen A, Pretorius ES, Malamud D: Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract. Hum Reprod 2001; 16:1151-1154.
70. Barnhart KT, Pretorius ES, Shaunik A, Timbers K, Nasution M, Mauck C: Vaginal distribution of two volumes of the novel microbicide gel cellulose sulfate (2.5 and 3.5 mL). Contraception 2005; 72:65-70.
71. Barnhart KT, Pretorius ES, Timbers K, Shera D, Shabbout M, Malamud D: In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse. Contraception 2004; 70:498-505.
72. Kunz G, Beil D, Deiniger H, Einspanier A, Mall G, Leyendecker G: The uterine peristaltic pump. Normal and impeded sperm transport within the female genital tract. Adv Exp Med Biol 1997; 424:267-277.